Disease / condition

Hypercholesterolemia clinical trials

Free access to 435 studies·10+ countries·Updated daily24 recruiting
435
Total trials
10+
Countries
10+
Sponsors
24
Recruiting
By phase
N/A153
Phase 3110
Phase 258
Phase 455
Phase 140
By status
Completed349
Recruiting24
Terminated22
Unknown16
Not yet recruit...10
Top countries
United States of America80
Japan29
South Korea24
China20
Italy16
Top sponsors
Organon and Co50
Sanofi31
AstraZeneca22
Takeda12
Regeneron Pharmace...10
Recent trials
Latest clinical trials for Hypercholesterolemia
NCT06368258Not yet recr...
Middle Term Effect of Red Yeast Rice on Plasma Lipids and Proteoma in Individuals With Suboptimal Cholesterolemia
University of BolognaItaly
NCT06301906Recruiting
Red Yeast Rice for Primary Prevention of Hypercholesterolemia
Chang Gung Memorial HospitalTaiwan
NCT06287177Recruiting
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
Federico II UniversityItaly
NCT06247137Completed
Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic Inflammation
University of BolognaItaly
NCT06243484Recruiting
Effect of the Food Supplement TOTUM-070 on Lipid Metabolism
ValbiotisGermany
RBR-6jmr68mRecruitment ...
Clinical study of a Type of Vitamin E obtained from the annatto in the control of High Cholesterol
Hospital das Clínicas da Unive...Brazil
jRCT2051230055Not yet recr...
Untitled Trial
Kowa Company, Ltd.
NCT05923281·Phase 3Recruiting
A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance
Kowa Company, Ltd.Japan
ANZCTR12623000439640·Phase 1Not yet recr...
A Study to Evaluate SGB-3403 in Healthy Volunteers
Sanegene Bio Australia Pty LtdAustralia
NCT05836909Enrolling by...
Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene
Lili YangChina
NCT05795517·Phase 2Recruiting
Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease(NAFLD)
Haisco Pharmaceutical Group Co...China
NCT05763875·Phase 3Recruiting
Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.
Novartis PharmaceuticalsUnited States of America
NCT05762276·Phase 1Recruiting
A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Compared With Placebo in Adult Participants
Vaxxinity, Inc.Australia
NCT05733325Not yet recr...
Diet-induced Elevations in LDL-C and Progression of Atherosclerosis
Lundquist Institute for Biomed...United States of America
NCT05694260·Phase 2Recruiting
A Phase 2 Clinical Study in Children With HeFH Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing
Esperion Therapeutics, Inc.Canada,Germany,United States of America
NCT05680844Recruiting
Peripheral Treg Cell Senescence & Serum Total Cholesterol Level
Tianjin Medical UniversityChina
NCT05438069Recruiting
German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany
Jena University HospitalGermany
NCT05430828Completed
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
Federico II UniversityItaly
NCT05362903Recruiting
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting
Novartis PharmaceuticalsGermany
jRCT2031210701Completed
Untitled Trial
MSD K.K.the United States of America;Germany;Norway;the United Kingdom;Turkey;Russia;Mexico;Korea
About this record

Access comprehensive clinical trial information for Hypercholesterolemia through Pure Global AI's free database. This collection includes 435 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 24 trials are actively recruiting participants.

Research for Hypercholesterolemia is being conducted in United States of America, Japan, South Korea and 7+ other countries. Leading sponsors include Organon and Co and Sanofi. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 435 clinical trials studying Hypercholesterolemia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Organon and Co, Sanofi, AstraZeneca, among others.